Accelerate Diagnostics, Inc. (AXDX)
NASDAQ: AXDX · Real-Time Price · USD
1.700
-0.050 (-2.86%)
Nov 20, 2024, 4:00 PM EST - Market closed
Accelerate Diagnostics Market Cap
Accelerate Diagnostics has a market cap or net worth of $40.25 million as of November 21, 2024. Its market cap has decreased by -51.09% in one year.
Market Cap
40.25M
Enterprise Value
78.32M
1-Year Change
-51.09%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since December 1, 1998, Accelerate Diagnostics's market cap has increased from $21.70M to $40.25M, an increase of 85.51%. That is a compound annual growth rate of 2.41%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 20, 2024 | 42.60M | -25.26% |
Dec 29, 2023 | 57.00M | -18.57% |
Dec 30, 2022 | 70.00M | -79.56% |
Dec 31, 2021 | 342.50M | -20.77% |
Dec 31, 2020 | 432.30M | -53.19% |
Dec 31, 2019 | 923.50M | 48.16% |
Dec 31, 2018 | 623.30M | -57.06% |
Dec 29, 2017 | 1.45B | 35.99% |
Dec 30, 2016 | 1.07B | 11.02% |
Dec 31, 2015 | 961.40M | 12.30% |
Dec 31, 2014 | 856.10M | 69.22% |
Dec 31, 2013 | 505.90M | 395.49% |
Dec 31, 2012 | 102.10M | 661.94% |
Dec 30, 2011 | 13.40M | 26.42% |
Dec 31, 2010 | 10.60M | 23.26% |
Dec 31, 2009 | 8.60M | -63.40% |
Dec 31, 2008 | 23.50M | -49.13% |
Dec 31, 2007 | 46.20M | 132.16% |
Dec 29, 2006 | 19.90M | -34.32% |
Dec 30, 2005 | 30.30M | 44.98% |
Dec 31, 2004 | 20.90M | -1.88% |
Dec 31, 2003 | 21.30M | 56.62% |
Dec 31, 2002 | 13.60M | -16.05% |
Dec 31, 2001 | 16.20M | 575.00% |
Dec 29, 2000 | 2.40M | -76.47% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Achilles Therapeutics | 43.14M |
Daxor | 43.11M |
OS Therapies | 43.02M |
LAVA Therapeutics | 42.86M |
Xilio Therapeutics | 42.74M |
Reviva Pharmaceuticals Holdings | 42.47M |
Omega Therapeutics | 42.20M |
NeueHealth | 41.51M |